MRNA (STOCKS)
Moderna, Inc. Common Stock
$52.000000
+2.090000 (+4.19%)
Prev close: $49.910000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Stéphane Bancel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $20,692.40M
- Employees
- 5,800
- P/E (TTM)
- -6.13
- P/B (TTM)
- 2.67
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
4
Buy
19
Hold
4
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-3.40 | $-4.04 | +0.6402 | +15.85% |
|
Dec 2025 (Q4)
|
$-2.11 | $-2.70 | +0.5853 | +21.72% |
|
Sep 2025 (Q3)
|
$-0.51 | $-2.15 | +1.6394 | +76.27% |
|
Jun 2025 (Q2)
|
$-2.13 | $-3.03 | +0.8957 | +29.60% |
Financial Statements
| Revenues | $2.23B |
| Benefits Costs and Expenses | $5.36B |
| Cost Of Revenue | $1.73B |
| Costs And Expenses | $5.64B |
| Gross Profit | $492.00M |
| Operating Expenses | $3.90B |
| Research and Development | $2.93B |
| Other Operating Expenses | $979.00M |
| Operating Income/Loss | -$3.41B |
| Income/Loss Before Equity Method Investments | -$3.14B |
| Income/Loss From Continuing Operations After Tax | -$3.19B |
| Income/Loss From Continuing Operations Before Tax | -$3.14B |
| Income/Loss From Equity Method Investments | -$2.00M |
| Income Tax Expense/Benefit | $56.00M |
| Net Income/Loss | -$3.19B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$3.19B |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.19B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$8.15 |
| Diluted Earnings Per Share | -$8.15 |
| Basic Average Shares | 1,174,000,000 |
| Diluted Average Shares | 1,174,000,000 |
| Assets | $11.49B |
| Current Assets | $5.77B |
| Inventory | $146.00M |
| Other Current Assets | $5.62B |
| Noncurrent Assets | $5.72B |
| Liabilities | $4.08B |
| Current Liabilities | $2.40B |
| Accounts Payable | $161.00M |
| Wages | $108.00M |
| Other Current Liabilities | $2.13B |
| Noncurrent Liabilities | $1.69B |
| Equity | $7.41B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.41B |
| Liabilities And Equity | $11.49B |
| Net Cash Flow From Operating Activities | -$1.47B |
| Net Cash Flow From Operating Activities, Continuing | -$1.47B |
| Net Cash Flow From Investing Activities | $1.14B |
| Net Cash Flow From Investing Activities, Continuing | $1.14B |
| Net Cash Flow From Financing Activities | $606.00M |
| Net Cash Flow From Financing Activities, Continuing | $606.00M |
| Net Cash Flow | $281.00M |
| Net Cash Flow, Continuing | $280.00M |
| Comprehensive Income/Loss | -$3.18B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$3.18B |
| Other Comprehensive Income/Loss | -$3.18B |
| Other Comprehensive Income/Loss Attributable To Parent | $15.00M |